Price Competition and the International Pharmaceutical Industry
Sanjaya Lall
Chapter 8 in The Multinational Corporation, 1980, pp 199-215 from Palgrave Macmillan
Abstract:
Abstract The issue of the pricing of pharmaceutical products has aroused considerable controversy over the past two decades. Much impassioned debate has ranged around whether the large firms which dominate the industry in developed as well as less-developed countries exercise excessive market power, whether the market power conferred on them legally (by patents) or by commercial practice (advertising of brand names) is abused by charging prices higher than social interest warrants, and what measures (if any) governments should adopt to regulate the pricing and other activities of large firms while maintaining a commercial incentive to invest in innovation.2 The US leads in the public debate on these problems, with the FDA (Food and Drug Administration) vigorously seeking to lower prices of drugs for its health programmes and to diminish the hold that brand names exercise over the choice of drugs. Several European countries have launched comprehensive schemes of price control, while a large number of LDCs are starting on the difficult path of pharmaceutical regulation and reduction in the cost of medicines to the public.
Keywords: Large Firm; Market Power; Multinational Corporation; Price Competition; Price Differential (search for similar items in EconPapers)
Date: 1980
References: Add references at CitEc
Citations:
There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.
Related works:
Journal Article: Price Competition and the International Pharmaceutical Industry (1978)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-1-349-05228-8_8
Ordering information: This item can be ordered from
http://www.palgrave.com/9781349052288
DOI: 10.1007/978-1-349-05228-8_8
Access Statistics for this chapter
More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().